Document is current
Any future updates will be listed below
-
Authors
Lin, Yunhan
Xu, Chenyang
Tao, Yanbao
Sun, Yaoyao
Liyanage, Biman Najika
Yue, Weihua
Shi, Chuan
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82330042,72110107003)
National Natural Science Foundation of China (No. 82330042,72110107003)
National Key R&D Program of China (2023YFE0119400)
the Fundamental Research Funds for the Central Universities (Peking University Medicine Fund for world’s leading discipline or discipline cluster development (BMU2022DJXK007)
AI+ Health Collaborative Innovation Cultivation Program from Beijing Municipal Science &Technology Commission, Administrative Commission of Zhongguancun Science Park (No. Z221100003522025)
- License Information
-
More Information
Article History
Received: 9 June 2025
Accepted: 24 July 2025
First Online: 20 November 2025
Declarations
:
: This study was approved by the Ethics Committee of Peking University Sixth Hospital, reference number 2022 LUNSHEN62. Clinical trial registration: Registered at ClinicalTrials.gov. Clinical trial number: ChiCTR2500095151. All participants provided written informed consent prior to participation in the study.
: All participants provided written informed consent prior to participation in the study. The participants consented to the collection, analysis, and publication of the experimental data. The study ensured that all personal data of patients were anonymized before data analysis.
: The authors declare no competing interests.
